Steris (STE) Cost of Revenue (2018 - 2026)

Steris' Cost of Revenue history runs 9 years deep, the most recent figure standing at $891.2 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 6.17% year-over-year to $891.2 million in Q1 2026; TTM through Mar 2026 was $3.3 billion, a 8.26% increase from a year earlier, with the FY2026 full-year figure at $3.3 billion, up 8.26% from the prior year.
• Cost of Revenue rose to $891.2 million in Q1 2026 per STE's latest filing, from $840.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $891.2 million in Q1 2026 and bottomed at $577.8 million in Q2 2022.
• The 5-year median for Cost of Revenue is $737.7 million (2023), against an average of $734.2 million.
• Biggest YoY gain for Cost of Revenue was 29.44% in 2022; the steepest drop was 15.07% in 2022.
• Year by year, Cost of Revenue stood at $634.2 million in 2022, then gained by 16.31% to $737.7 million in 2023, then rose by 3.05% to $760.2 million in 2024, then increased by 10.59% to $840.7 million in 2025, then climbed by 6.01% to $891.2 million in 2026.
• Per Business Quant, the three latest STE Cost of Revenue figures stand at $891.2 million (Q1 2026), $840.7 million (Q4 2025), and $814.4 million (Q3 2025).